LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Correction: Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

    Annals of internal medicine

    2021  Volume 174, Issue 6, Page(s) 888

    Language English
    Publishing date 2021-06-14
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/L21-0148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.

    Al-Samkari, Hanny / Gupta, Shruti / Leaf, Rebecca Karp / Wang, Wei / Rosovsky, Rachel P / Brenner, Samantha K / Hayek, Salim S / Berlin, Hanna / Kapoor, Rajat / Shaefi, Shahzad / Melamed, Michal L / Sutherland, Anne / Radbel, Jared / Green, Adam / Garibaldi, Brian T / Srivastava, Anand / Leonberg-Yoo, Amanda / Shehata, Alexandre M / Flythe, Jennifer E /
    Rashidi, Arash / Goyal, Nitender / Chan, Lili / Mathews, Kusum S / Hedayati, S Susan / Dy, Rajany / Toth-Manikowski, Stephanie M / Zhang, Jingjing / Mallappallil, Mary / Redfern, Roberta E / Bansal, Amar D / Short, Samuel A P / Vangel, Mark G / Admon, Andrew J / Semler, Matthew W / Bauer, Kenneth A / Hernán, Miguel A / Leaf, David E

    Annals of internal medicine

    2021  Volume 174, Issue 5, Page(s) 622–632

    Abstract: ... major bleeding in critically ill patients with COVID-19 and examine the observational effect ... of early therapeutic anticoagulation on survival.: Design: In a multicenter cohort study of 3239 critically ill ... to examine the observational effect of early therapeutic anticoagulation on survival. A Cox model ...

    Abstract Background: Hypercoagulability may be a key mechanism of death in patients with coronavirus disease 2019 (COVID-19).
    Objective: To evaluate the incidence of venous thromboembolism (VTE) and major bleeding in critically ill patients with COVID-19 and examine the observational effect of early therapeutic anticoagulation on survival.
    Design: In a multicenter cohort study of 3239 critically ill adults with COVID-19, the incidence of VTE and major bleeding within 14 days after intensive care unit (ICU) admission was evaluated. A target trial emulation in which patients were categorized according to receipt or no receipt of therapeutic anticoagulation in the first 2 days of ICU admission was done to examine the observational effect of early therapeutic anticoagulation on survival. A Cox model with inverse probability weighting to adjust for confounding was used.
    Setting: 67 hospitals in the United States.
    Participants: Adults with COVID-19 admitted to a participating ICU.
    Measurements: Time to death, censored at hospital discharge, or date of last follow-up.
    Results: Among the 3239 patients included, the median age was 61 years (interquartile range, 53 to 71 years), and 2088 (64.5%) were men. A total of 204 patients (6.3%) developed VTE, and 90 patients (2.8%) developed a major bleeding event. Independent predictors of VTE were male sex and higher D-dimer level on ICU admission. Among the 2809 patients included in the target trial emulation, 384 (11.9%) received early therapeutic anticoagulation. In the primary analysis, during a median follow-up of 27 days, patients who received early therapeutic anticoagulation had a similar risk for death as those who did not (hazard ratio, 1.12 [95% CI, 0.92 to 1.35]).
    Limitation: Observational design.
    Conclusion: Among critically ill adults with COVID-19, early therapeutic anticoagulation did not affect survival in the target trial emulation.
    Primary funding source: None.
    MeSH term(s) Aged ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Blood Coagulation Disorders/drug therapy ; Blood Coagulation Disorders/mortality ; Blood Coagulation Disorders/virology ; COVID-19/complications ; COVID-19/mortality ; Critical Illness ; Female ; Hemorrhage/chemically induced ; Hemorrhage/mortality ; Hemorrhage/virology ; Humans ; Intensive Care Units ; Male ; Middle Aged ; SARS-CoV-2 ; Survival Rate ; United States/epidemiology ; Venous Thromboembolism/drug therapy ; Venous Thromboembolism/mortality ; Venous Thromboembolism/virology
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2021-01-26
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/M20-6739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top